We are live on
!
Find out more
GCM
Gallacher Capital Management Portfolio holdings
AUM
$178M
1-Year Est. Return
29.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+29.29%
3 Year Est. Return
+70.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
–
Cap. Flow
+$169M
Cap. Flow
% of AUM
102.16%
Top 10 Holdings %
Top 10 Hldgs %
38.47%
Holding
230
New
230
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLNA
Filana Therapeutics
FLNA
|
+$21.2M |
| 2 |
PepsiCo
PEP
|
+$18.3M |
| 3 |
Yum! Brands
YUM
|
+$5.33M |
| 4 |
Vanguard Total Bond Market
BND
|
+$4.2M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$3.98M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.5% |
| 2 | Consumer Staples | 12.79% |
| 3 | Consumer Discretionary | 8.62% |
| 4 | Technology | 7.2% |
| 5 | Financials | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AstraZeneca
AZN
$251B
| $279K | 0.17% |
+2,059
| New | +$258K |
|
152
Columbia Diversified Fixed Income Allocation ETF
DIAL
$387M
| $277K | 0.17% |
+16,030
| New | +$275K |
|
153
CRH
CRH
$66.9B
| $274K | 0.17% |
+6,891
| New | +$258K |
|
154
GSK
GSK
$104B
| $273K | 0.17% |
+7,777
| New | +$259K |
|
155
Sony
SONY
$140B
| $273K | 0.17% |
+17,885
| New | +$267K |
|
156
iShares Core MSCI EAFE ETF
IEFA
$195B
| $273K | 0.17% |
+4,426
| New | +$260K |
|
157
Ryder
R
$9.98B
| $271K | 0.16% |
+3,243
| New | +$272K |
|
158
Oracle
ORCL
$435B
| $270K | 0.16% |
+3,301
| New | +$251K |
|
159
British American Tobacco
BTI
$123B
| $269K | 0.16% |
+6,737
| New | +$265K |
|
160
Applied Materials
AMAT
$415B
| $267K | 0.16% |
+2,741
| New | +$263K |
|
161
Pfizer
PFE
$154B
| $266K | 0.16% |
+5,185
| New | +$249K |
|
162
Ryanair
RYAAY
$30.9B
| $264K | 0.16% |
+8,840
| New | +$251K |
|
163
Altria Group
MO
$109B
| $264K | 0.16% |
+5,777
| New | +$262K |
|
164
Devon Energy
DVN
$49.9B
| $263K | 0.16% |
+4,269
| New | +$291K |
|
165
STMicroelectronics
STM
$48.5B
| $262K | 0.16% |
+7,371
| New | +$260K |
|
166
Mitsubishi UFJ Financial
MUFG
$251B
| $261K | 0.16% |
+39,092
| New | +$202K |
|
167
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $260K | 0.16% |
+4,355
| New | +$258K |
|
|
TEF
168
DELISTED
Telefonica
TEF
| $259K | 0.16% |
+72,588
| New | +$254K |
|
169
iShares MSCI EAFE ETF
EFA
$79.8B
| $259K | 0.16% |
+3,941
| New | +$247K |
|
170
Eagle Materials
EXP
$6.47B
| $254K | 0.15% |
+1,911
| New | +$241K |
|
171
DT Midstream
DTM
$13.7B
| $252K | 0.15% |
+4,567
| New | +$261K |
|
172
BP
BP
$110B
| $251K | 0.15% |
+7,187
| New | +$239K |
|
173
Nokia
NOK
$51B
| $251K | 0.15% |
+54,081
| New | +$249K |
|
174
Ameriprise Financial
AMP
$49.2B
| $250K | 0.15% |
+804
| New | +$245K |
|
175
ING
ING
$101B
| $248K | 0.15% |
+20,391
| New | +$221K |
|
Similar funds
PS
CNWM
CCM
WAM
SMTF
NRWA
ACM
SMP
Gallacher Capital Management's Q4 2022 Portfolio in Review
Q4 2022 is the first quarter with a 13F filing on record for Gallacher Capital Management, which disclosed 230 positions worth $165M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Filana Therapeutics: 588,533 shares worth $17.4M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Staples and Consumer Discretionary.
- Gallacher Capital Management's largest Q4 2022 buy was Filana Therapeutics: 588,533 shares worth $17.4M.
- Gallacher Capital Management's ten largest holdings make up 38% of its $165M portfolio in Q4 2022.
- Gallacher Capital Management disclosed 230 positions in Q4 2022, its first 13F filing on record.
Based on Gallacher Capital Management's 13F filing for Q4 2022, filed 17 Jan 2023.